Completed NA INTERVENTIONAL 3-arm NCT01335984

Effects of Telemonitoring and Telemedicine Service for Hypertensive Care (Smart-HTN)

A Multi-center, Randomized, Parallel, Interventional, Open Label Trial to Compare the Blood Pressure-lowering Effect of Conventional Treatment and Smart Care Service in Hypertensive Patients Receiving Any Conventional Treatment

Sponsor: Chang Hee, Lee

Conditions Hypertension

Interventions Telemonitoring Telemonitoring & Telemedicine control group

Updated 8 times since 2017 Last updated: Jan 29, 2020 Started: Jan 31, 2011 Primary completion: Apr 30, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hypertension and is currently completed. Chang Hee, Lee leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Feb 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Feb 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chang Hee, Lee
LG Electronics Inc.
Purdue University

Data source: LG Electronics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Daegu, South Korea
• Seoul, South Korea